The fact that it has taken this long to release TLD+publication makes me think they strongly believe FDA is on their side too, but they are being extra cautious with FDA and letting them take care of their internal processes and red tapes.
Either way, from a valuation perspective we ought to be close to $3-4 SP with UK and EU approvals. FDA approvals doubles that valuation in my mind.
Market Data 
Markets 
AI
